76 results
8-K
EX-10.2
LSTA
Lisata Therapeutics, Inc.
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am
or records given or reports made to the Company by an independent certified public accountant or by an appraiser or other expert selected
424B3
LSTA
Lisata Therapeutics, Inc.
29 Jul 22
Prospectus supplement
4:06pm
is not a legal, regulatory, tax or accounting expert and relied on the assessments made by Caladrius and its advisors with respect to such issues. Back Bay … experience.
Michael H. Davidson, M.D. Dr. Davidson joined the Caladrius Board of Directors in July 2020. He is an industry leader and expert
425
37uv47zn58
27 Apr 22
Business combination disclosure
5:26pm
8-K
npd4u
28 Jul 20
Caladrius Biosciences Appoints Dr. Michael H. Davidson
8:24am
8-K
EX-99.1
vawxj0dz835fglvh
28 Jul 20
Caladrius Biosciences Appoints Dr. Michael H. Davidson
8:24am
424B5
am1 9aw2z82n4bjil08
14 Mar 19
Prospectus supplement for primary offering
4:23pm
424B5
lvbwxrq9v
3 Jun 14
Prospectus supplement for primary offering
12:00am
8-K
hosd3
14 Apr 14
Entry into a Material Definitive Agreement
12:00am